Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 1
2019 1
2020 4
2021 6
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mare de vries[Author] (7 results)?
Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties.
Ural BB, Yeung ST, Damani-Yokota P, Devlin JC, de Vries M, Vera-Licona P, Samji T, Sawai CM, Jang G, Perez OA, Pham Q, Maher L, Loke P, Dittmann M, Reizis B, Khanna KM. Ural BB, et al. Among authors: de vries m. Sci Immunol. 2020 Mar 27;5(45):eaax8756. doi: 10.1126/sciimmunol.aax8756. Sci Immunol. 2020. PMID: 32220976 Free PMC article.
Long noncoding RNA CHROMR regulates antiviral immunity in humans.
van Solingen C, Cyr Y, Scacalossi KR, de Vries M, Barrett TJ, de Jong A, Gourvest M, Zhang T, Peled D, Kher R, Cornwell M, Gildea MA, Brown EJ, Fanucchi S, Mhlanga MM, Berger JS, Dittmann M, Moore KJ. van Solingen C, et al. Among authors: de vries m. Proc Natl Acad Sci U S A. 2022 Sep 13;119(37):e2210321119. doi: 10.1073/pnas.2210321119. Epub 2022 Aug 24. Proc Natl Acad Sci U S A. 2022. PMID: 36001732 Free PMC article.
Generation of quality-controlled SARS-CoV-2 variant stocks.
de Vries M, Ciabattoni GO, Rodriguez-Rodriguez BA, Crosse KM, Papandrea D, Samanovic MI, Dimartino D, Marier C, Mulligan MJ, Heguy A, Desvignes L, Duerr R, Dittmann M. de Vries M, et al. Nat Protoc. 2023 Dec;18(12):3821-3855. doi: 10.1038/s41596-023-00897-6. Epub 2023 Oct 13. Nat Protoc. 2023. PMID: 37833423 Review.
The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target.
Rona G, Zeke A, Miwatani-Minter B, de Vries M, Kaur R, Schinlever A, Garcia SF, Goldberg HV, Wang H, Hinds TR, Bailly F, Zheng N, Cotelle P, Desmaële D, Landau NR, Dittmann M, Pagano M. Rona G, et al. Among authors: de vries m. Cell Death Differ. 2022 Feb;29(2):285-292. doi: 10.1038/s41418-021-00900-1. Epub 2021 Dec 3. Cell Death Differ. 2022. PMID: 34862481 Free PMC article.
ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection.
Ching KL, de Vries M, Gago J, Dancel-Manning K, Sall J, Rice WJ, Barnett C, Khodadadi-Jamayran A, Tsirigos A, Liang FX, Thorpe LE, Shopsin B, Segal LN, Dittmann M, Torres VJ, Cadwell K. Ching KL, et al. Among authors: de vries m. PLoS Biol. 2022 Sep 13;20(9):e3001754. doi: 10.1371/journal.pbio.3001754. eCollection 2022 Sep. PLoS Biol. 2022. PMID: 36099266 Free PMC article.
A comparative study of in vitro air-liquid interface culture models of the human airway epithelium evaluating cellular heterogeneity and gene expression at single cell resolution.
Prescott RA, Pankow AP, de Vries M, Crosse KM, Patel RS, Alu M, Loomis C, Torres V, Koralov S, Ivanova E, Dittmann M, Rosenberg BR. Prescott RA, et al. Among authors: de vries m. Respir Res. 2023 Aug 28;24(1):213. doi: 10.1186/s12931-023-02514-2. Respir Res. 2023. PMID: 37635251 Free PMC article.
ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection.
Ching KL, de Vries M, Gago J, Dancel-Manning K, Sall J, Rice WJ, Barnett C, Liang FX, Thorpe LE, Shopsin B, Segal LN, Dittmann M, Torres VJ, Cadwell K. Ching KL, et al. Among authors: de vries m. bioRxiv [Preprint]. 2021 Dec 23:2021.12.17.473223. doi: 10.1101/2021.12.17.473223. bioRxiv. 2021. PMID: 34981050 Free PMC article. Updated. Preprint.
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
Lokugamage KG, Hage A, de Vries M, Valero-Jimenez AM, Schindewolf C, Dittmann M, Rajsbaum R, Menachery VD. Lokugamage KG, et al. Among authors: de vries m. J Virol. 2020 Nov 9;94(23):e01410-20. doi: 10.1128/JVI.01410-20. Print 2020 Nov 9. J Virol. 2020. PMID: 32938761 Free PMC article.
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.
Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D, Higgs RE, Balasubramaniam D, Wang L, Zhang Y, Yang ES, Bidshahri R, Kraft L, Hwang Y, Žentelis S, Jepson KR, Goya R, Smith MA, Collins DW, Hinshaw SJ, Tycho SA, Pellacani D, Xiang P, Muthuraman K, Sobhanifar S, Piper MH, Triana FJ, Hendle J, Pustilnik A, Adams AC, Berens SJ, Baric RS, Martinez DR, Cross RW, Geisbert TW, Borisevich V, Abiona O, Belli HM, de Vries M, Mohamed A, Dittmann M, Samanovic MI, Mulligan MJ, Goldsmith JA, Hsieh CL, Johnson NV, Wrapp D, McLellan JS, Barnhart BC, Graham BS, Mascola JR, Hansen CL, Falconer E. Jones BE, et al. Among authors: de vries m. Sci Transl Med. 2021 May 12;13(593):eabf1906. doi: 10.1126/scitranslmed.abf1906. Epub 2021 Apr 5. Sci Transl Med. 2021. PMID: 33820835 Free PMC article.
Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
Lokugamage KG, Hage A, de Vries M, Valero-Jimenez AM, Schindewolf C, Dittmann M, Rajsbaum R, Menachery VD. Lokugamage KG, et al. Among authors: de vries m. bioRxiv [Preprint]. 2020 Jul 13:2020.03.07.982264. doi: 10.1101/2020.03.07.982264. bioRxiv. 2020. PMID: 32511335 Free PMC article. Updated. Preprint.
21 results